Search Results - "Phillips, JT"

Refine Results
  1. 1

    A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis by Polman, Chris H, O'Connor, Paul W, Havrdova, Eva, Hutchinson, Michael, Kappos, Ludwig, Miller, David H, Phillips, J. Theodore, Lublin, Fred D, Giovannoni, Gavin, Wajgt, Andrzej, Toal, Martin, Lynn, Frances, Panzara, Michael A, Sandrock, Alfred W

    Published in The New England journal of medicine (02-03-2006)
    “…This placebo-controlled, randomized trial of patients with relapsing multiple sclerosis demonstrated benefits of natalizumab (an α 4 integrin antagonist) in…”
    Get full text
    Journal Article
  2. 2

    Immune surveillance in multiple sclerosis patients treated with natalizumab by Stüve, Olaf, Marra, Christina M., Jerome, Keith R., Cook, Linda, Cravens, Petra D., Cepok, Sabine, Frohman, Elliot M., Phillips, J. Theodore, Arendt, Gabriele, Hemmer, Bernhard, Monson, Nancy L., Racke, Michael K.

    Published in Annals of neurology (01-05-2006)
    “…Objective Our objective was to test whether natalizumab, an antibody against very late activating antigen (VLA)‐4, interferes with central nervous system…”
    Get full text
    Journal Article
  3. 3

    Interferon beta-1b in secondary progressive MS: Results from a 3-year controlled study by Panitch, Hillel, Miller, Aaron, Paty, Donald, Weinshenker, Brian

    Published in Neurology (23-11-2004)
    “…To evaluate the efficacy and safety of interferon beta-1b (IFNbeta-1b) in subjects with secondary progressive multiple sclerosis (SPMS). This 3-year,…”
    Get full text
    Journal Article
  4. 4
  5. 5

    P2-12-32: Association between Progranulin (GP88) Expression and Recurrence Risk for Breast Cancer Patients with Estrogen Receptor Positive Invasive Ductal Carcinoma by Serrero, G, Hawkins, DM, Ioffe, O, Bejarano, P, Phillips, JT, Head, JF, Elliott, RL, Godwin, AK, Weaver, J, Yue, B

    Published in Cancer research (Chicago, Ill.) (15-12-2011)
    “…Abstract Purpose: GP88 (progranulin) is a critical player of breast tumorigenesis for estrogen receptor positive (ER+) breast cancer. Pathological studies…”
    Get full text
    Journal Article
  6. 6

    Gender effects on intramuscular interferon beta-1a in relapsing–remitting multiple sclerosis: analysis of 1406 patients by Rudick, RA, Kappos, L, Kinkel, R, Clanet, M, Phillips, JT, Herndon, RM, Sandrock, AW, Munschauer, FE

    Published in Multiple sclerosis (01-03-2011)
    “…Background: We aimed to evaluate effects of gender on efficacy and safety of intramuscular (IM) interferon beta (IFNβ)-1a in patients with relapsing–remitting…”
    Get full text
    Journal Article
  7. 7

    A clinical therapeutic trial of cyclosporine in myasthenia gravis by Tindall, R S, Phillips, J T, Rollins, J A, Wells, L, Hall, K

    Published in Annals of the New York Academy of Sciences (21-06-1993)
    “…We randomly assigned 39 patients with steroid-dependent generalized myasthenia gravis to treatment with cyclosporine (5 mg/kg per body weight in divided doses)…”
    Get more information
    Journal Article
  8. 8

    An open-label safety and drug interaction study of natalizumab (Antegren™) in combination with interferon-beta (Avonex®) in patients with multiple sclerosis by Vollmer, T L, Phillips, J T, Goodman, A D, Agius, M A, Libonati, M A, Giacchino, J L, Grundy, J S

    Published in Multiple sclerosis (01-10-2004)
    “…In this open-label drug-interaction trial, we studied 38 patients with relapsing-remitting multiple sclerosis (MS) who received 3.0 or 6.0 mg/kg of natalizumab…”
    Get full text
    Journal Article
  9. 9

    Disease modifying agent related skin reactions in multiple sclerosis: prevention, assessment, and management by Frohman, E M, Brannon, K, Alexander, Sherry, Sims, D, Phillips, J T, O'Leary, S, Hawker, K, Racke, M K

    Published in Multiple sclerosis (01-06-2004)
    “…Background: The objective for this article is to highlight some of the adverse skin manifestations associated with injectable disease modifying therapy for…”
    Get full text
    Journal Article
  10. 10

    Quantitative oculographic characterisation of internuclear ophthalmoparesis in multiple sclerosis: the versional dysconjugacy index Z score by Frohman, E M, Frohman, T C, O'Suilleabhain, P, Zhang, H, Hawker, K, Racke, M K, Frawley, W, Phillips, J T, Kramer, P D

    “…Background: There is a poor correlation between multiple sclerosis disease activity, as measured by magnetic resonance imaging, and clinical disability…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Characterizing the mechanisms of progression in multiple sclerosis: evidence and new hypotheses for future directions by Frohman, E M, Filippi, M, Stuve, O, Waxman, S G, Corboy, J, Phillips, J T, Lucchinetti, C, Wilken, J, Karandikar, N, Hemmer, B, Monson, N, De Keyser, J, Hartung, H, Steinman, L, Oksenberg, J R, Cree, B A C, Hauser, S, Racke, M K

    Published in Archives of neurology (Chicago) (01-09-2005)
    “…Major advancements have been achieved in our ability to diagnose multiple sclerosis (MS) and to commence treatment intervention with agents that can favorably…”
    Get more information
    Journal Article
  13. 13

    The utility of MRI in suspected MS: report of the Therapeutics and technology assessment Subcommittee of the American Academy of Neurology by Frohman, EM, Goodin, DS, Calabresi, PA, Corboy, JR, Coyle, PK, Filippi, M, Frank, JA, Galetta, SL, Grossman, RI, Hawker, K, Kachuck, NJ, Levin, MC, Phillips, JT, Racke, MK, Rivera, VM, Stuart, WH

    Published in American journal of ophthalmology (01-02-2004)
    “…[...]the presence of two or more gadolinium (Gd)-enhancing lesions at baseline and the appearance of either new T2 lesions or new Gd enhancement on follow-up…”
    Get full text
    Journal Article
  14. 14

    Preliminary results of a double-blind, randomized, placebo-controlled trial of cyclosporine in myasthenia gravis by Tindall, R S, Rollins, J A, Phillips, J T, Greenlee, R G, Wells, L, Belendiuk, G

    Published in The New England journal of medicine (19-03-1987)
    “…We randomly assigned 20 patients with progressively worsening generalized myasthenia gravis of recent onset whose illness was not controlled by…”
    Get more information
    Journal Article
  15. 15

    Prolactin Stimulates Proliferation of Cultured Human Keratinocytes by Girolomoni, Giampiero, Phillips, J Theodore, Bergstresser, Paul R

    Published in Journal of investigative dermatology (01-09-1993)
    “…The effect of the pituitary hormone prolactin on in vitro proliferation of human keratinocytes has been studied. Cell proliferation was determined by [3H]…”
    Get full text
    Journal Article Conference Proceeding
  16. 16

    Modification of acute experimental autoimmune encephalomyelitis in the Lewis rat by oral administration of type 1 interferons by Brod, S A, Scott, M, Burns, D K, Phillips, J T

    Published in Journal of interferon & cytokine research (01-02-1995)
    “…The effect of orally administered type 1 interferons on the severity of acute experimental autoimmune encephalomyelitis (EAE), a T cell-mediated autoimmune…”
    Get more information
    Journal Article
  17. 17
  18. 18

    Prolactin receptor expression by lymphoid tissues in normal and immunized rats by Koh, C Y, Phillips, J T

    Published in Molecular and cellular endocrinology (01-04-1993)
    “…Prolactin receptor (PRLr) expression and distribution in thymus, spleen, bone marrow, lymph nodes, and peripheral blood lymphocytes from young adult Lewis rats…”
    Get more information
    Journal Article
  19. 19
  20. 20